Brand Name Extensions by Pharma May Finally Be Receiving Scrutiny?
On July 6, the Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO), published a notice inviting comments on the use of brand name extensions by Pharma Companies. This stems from a representation made before the Drugs Consultative Committee alleging that a pharma company was selling different formulations under one brand name with different extensions. However, this problem has been a long-standing one, as explained by Prashant and Dinesh Thakur. In effect, this notice seems to be towards […]
Brand Name Extensions by Pharma May Finally Be Receiving Scrutiny? Read More »








